This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.

Rigante, D., Cipolla, C., Rossodivita, A. N., Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease, <<CLINICAL PEDIATRIC ENDOCRINOLOGY>>, 2018; 2018 (27(2)): 101-105. [doi:10.1297/cpe.27.101] [http://hdl.handle.net/10807/118955]

Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease

Rigante, Donato
;
Cipolla, Clelia;Rossodivita, Aurora Natalia
2018

Abstract

This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.
2018
Inglese
Rigante, D., Cipolla, C., Rossodivita, A. N., Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease, <<CLINICAL PEDIATRIC ENDOCRINOLOGY>>, 2018; 2018 (27(2)): 101-105. [doi:10.1297/cpe.27.101] [http://hdl.handle.net/10807/118955]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/118955
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact